Research Article
Solidified Reverse Micellar Solution- (SRMS-) Based Microparticles for Enhanced Oral Bioavailability and Systemic Antifungal Efficacy of Miconazole Nitrate in Immunocompromised Mice
Table 4
Pharmacokinetic parameters of formulations.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MN: miconazole nitrate; Batch : 5% LM1, containing 3% MN; Batch : 5% LM2 containing 3% MN; Batch : 5% LM3 containing 3% MN (values presented as the , ). |